In an exclusive interview with CNBC-TV18, Rakesh Parikh CFO of Unichem Laboratories says the company’s Q4 outlook is on the lines of the Q3 growth and the investments made are likely to reap benefits soon. “The India formulation business is continuing in the same as in Q3. We will wrap up the year with double digit growth.”
first published: Mar 31, 2011 01:45 pm
A collection of the most-viewed Moneycontrol videos.
Realty, PSU Banks Lead Nifty Back Near 25,800; Shriram Finance Scales Record High| Closing Bell Live
Will D-Street See A Sweet Start To November? Autos In Focus After Record Sales| Opening Bell Live
The Sikkim Girl Trying to Make it Big in Mumbai | Tenant
Live: Nifty snaps 4-week gains, slips below 25,800 | Closing Bell
